ID   VIPI
AC   CVCL_A1YR
DR   Wikidata; Q105511706
RX   PubMed=24443327;
CC   Group: Cancer stem cell line.
CC   Doubling time: 18 hours (PubMed=24443327).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=24443327; DOI=10.1002/ijc.28680;
RA   Vecchio D., Daga A., Carra E., Marubbi D., Baio G., Neumaier C.E.,
RA   Vagge S., Corvo R., Brisigotti M.P., Ravetti J.L., Zunino A.,
RA   Poggi A., Mascelli S., Raso A., Frosina G.;
RT   "Predictability, efficacy and safety of radiosensitization of
RT   glioblastoma-initiating cells by the ATM inhibitor KU-60019.";
RL   Int. J. Cancer 135:479-491(2014).
//